GE Healthcare's Discovery Dimension is designed to help clinicians advance toward the goal of motion-free PET/CT imaging, addressing the PET and CT imaging mismatches related to respiratory and cardiac motion. These include motion correction techniques that effectively improve clinical results and minimize blur caused by motion.
Discovery Dimension reportedly provides high-definition PET image processing, patient motion management and clinical productivity features that together address motion.
July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...
July 02, 2024 
June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 18, 2024 
June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 14, 2024 
June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...
June 10, 2024 
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
May 14, 2024 
April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...
April 23, 2024 
January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...
January 23, 2024 
January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...
January 22, 2024 
December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...
December 27, 2023 
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
December 06, 2023